DANIEL KLABER: Open Payments
NPI 1073002465 · BUTLER, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$784 in 39 payments from 22 companies in 2025. Trend: 2023 $289 · 2024 $956 · 2025 $784
Food & beverage: $784
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $81 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $73 |
| Alkermes, Inc. | 2 | $69 |
| Dexcom, Inc. | 3 | $66 |
| ABBVIE INC. | 3 | $55 |
| Otsuka America Pharmaceutical, Inc. | 2 | $42 |
| Axsome Therapeutics, Inc. | 2 | $38 |
| Teva Pharmaceuticals USA, Inc. | 2 | $36 |
| GlaxoSmithKline, LLC. | 2 | $36 |
| Exact Sciences Corporation | 2 | $32 |
Products named: Kerendia, XIFAXAN, VIVITROL, Dexcom G6 Transmitter, REXULTI, VRAYLAR, Auvelity, AUSTEDO XR.
Industry payments across KY — which companies pay providers there.
